key: cord-0730917-egujvahf
authors: Ganz, Troy J.; Donner, Rachel; Hines, Kevin M.; Waithe-Alleyne, Markus L.; Slate, Deirdre L.; Abel, Gyorgy; Auclair, Jared R.
title: Two-Stage Hierarchical Group Testing Strategy to Increase SARS-CoV-2 Testing Capacity at an Institution of Higher Education: A Retrospective Analysis
date: 2021-09-23
journal: J Mol Diagn
DOI: 10.1016/j.jmoldx.2021.09.001
sha: 855af621891b480bbccc820cabd8fc65c8af83b2
doc_id: 730917
cord_uid: egujvahf

Population testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is necessary owing to the potential for viral transmission from asymptomatic cases, yet scarcity of reagents and equipment has increased the cost-prohibitive implementation of screening campaigns at institutions of higher education. Significant analytical sensitivities of nucleic acid amplification methods permit sample pooling to increase testing capacity. Statistical models compared optimal testing configuration for pools of 3, 5, and 10 samples. Assessment of pooling using the TaqPath COVID-19 Combo Kit multiplex assay (ORF1ab, N, and S gene targets) involved a limit of detection (LOD) study, matrix effect study, and clinical comparison of neat to pooled sample. An LOD of 135.02 (ORF1ab; CI.95: 117.21-155.52), 373.92 (N; CI.95: 257.05-437.64), and 1001.32 (S; CI.95: 896.62-1118.33) gce per milliliter was resolved. Seventy-two randomly selected samples demonstrated slight suppression due to negative sample matrix. Resulting mean cycle threshold (CT) shifts were 2.09 (ORF1ab), 1.76 (N), and 2.31 (S) for the 3-pool, 2.83 (ORF1ab), 2.45 (N), and 3.24 (S) for the 5-pool, and 3.99 (ORF1ab), 3.46 (N), and 4.07 (S) for the 10-pool. Despite quantitative sensitivity loss trend, the qualitative result was unaffected in each pool. According to the range of disease prevalence observed at the testing site (0.03-7.32%), a pool of five samples was deemed an optimal and cost-effective option for monitoring the Northeastern University community.

The emerging pandemic of coronavirus disease , sourced from the novel strain of beta-coronavirus known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has had a severe impact on global healthcare systems [1] . Institutions of higher education (IHE) have been confronted with the conflicting obligations to guarantee a standard quality of education while ensuring the safety of their faculty, staff, and students during the pandemic. For universities with shared living, dining, transportation, and classroom learning arrangements, the greater requirements of risk management must be weighed against the economic loss of closing for an indeterminate period [2] . Further pressures are imposed upon IHE in urban environments as positive correlations of transmission have been observed with factors such as reduced air quality and higher population density [3] . As with other respiratory infections, transmission is facilitated by viral shedding in the upper respiratory tract that may release viral particles in the form of aerosols (≤5 µm) or droplets (>5 µm) to contaminate the surrounding air or surfaces, and spread via fomites, coughing, sneezing, and exhalation from symptomatic, as well as pre-symptomatic and asymptomatic, carriers [4, 5] . Along with recommended measures for risk management such as physical distancing, obligatory personal hygiene, and mask wearing, a rigorous screening and surveillance campaign provides the most effective response.

Quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) offers the most sensitive method for early detection of SARS-CoV-2 when compared to other available analytical methodologies, which may require larger viral loads or long periods J o u r n a l P r e -p r o o f of seroconversion following infection [6] . Additionally, accessibility of less invasive nasopharyngeal, oropharyngeal, and nare respiratory swab collections have demonstrable stability and result in better patient compliance [7] . Drawbacks coincide with the sharp increase in global demand for medical and testing supplies such as personal protective equipment (PPE; gloves, gowns, surgical and N95 masks), collection swabs and containers, transport and lysis buffers, nucleic acid extraction and amplification kits, consumables (e.g. micropipette tips), analytical equipment, and qualified technical personnel as the high-complexity format of RT-qPCR testing schema requires a reliable supply chain of critical materials.

Group testing, or sample pooling, is an attractive method to increase testing capacity without a need for additional resources or training. Methods in statistical modeling have been developed to predict optimal group sizes for both hierarchical and non-hierarchical testing algorithms parameterized by disease prevalence and testing error [8] . Pressured by the COVID-19 pandemic, investigators have sought to validate SARS-CoV-2 group testing on available molecular platforms [9, 10, 11] . As persistent evolution of SARS-CoV-2 variants pose a threat to vaccine efficacy, Northeastern University expects population screening to extend until evidence of a significant reduction in viral reproductive rate is attained. Thus, the following investigation sought to define an ideal pooling size with consideration to the impact on analytical sensitivity and operations efficiency as implementation of group testing will be crucial for an economical continuation of COVID-19 response.

J o u r n a l P r e -p r o o f

This study was conducted at the Life Science Testing Center (LSTC; Burlington, MA, USA) for Northeastern University (NU) students, faculty, and staff at regional campuses primarily in Boston MA, Portland ME, and Charlotte, NC. Since the establishment of the LSTC in August 2020, the site has observed an overall disease prevalence of 0.22% (CI.95: 0.11-0.33%). Students attending campus were required to test every three days (±1 day) while employees on site five days a week were expected to test at least twice a

week. As all affiliates are directed to a designated symptomatic or asymptomatic 

The prospective workflow can be modeled using an adaptive two-stage hierarchical algorithm, whereby results from the master pool direct repeat testing of the individual samples. An optimal testing configuration is the result of parameters including disease prevalence, group size, analytical sensitivity, and analytical specificity. Under nonpooling conditions, total assays informed by the assay controls could be expressed as = + 1, where E is the expected number of tests and n is the probability of repeat testing due to an invalidated test, (e.g., internal extraction control failure, external quality control failure). Pursuant to LSTC protocol, an invalid test is repeated once and further representation for the total assays could be expressed as = ( 2 ) + ( + 1). Utilizing an open-source statistical modeling application (University of Nebraska-Lincoln, www.chrisbilder.com/shiny/, last accessed September 1, 2020), the term E was included to achieve estimated reductions for pools of size 3, 5, and 10. Sensitivity was set to 95% based on the calculated limit of detection, while specificity was set to 99% under the combined influence of the assay controls and operator review. 

The average rate of invalid tests from December 2020 to June 2021 was 5.43% (CI.95:

3.56-7.29%), of which 0.46% (CI.95: 0.26-0.66%) were due to internal extraction control failure while the remainder was due to external control failure, suspected contamination, or technical error. Consideration of these probabilities affecting a pooled sample twice informed the testing reductions of 5000 samples for pools of 3, 5, and 10 ( Figure 1 ).

Over the range of repeat rates, the 10-pool was optimal at prevalence <2%, however the 5-pool consistently outperformed both 3-pool and 10-pool formats until prevalence >10%. Interestingly, the impact of repeat testing due to invalid assays appear to be J o u r n a l P r e -p r o o f overtaken by deconvolution at increased disease prevalence. Examination within the range of expected prevalence (0.03-7.32%) indicates the pooling method influences a favorable decrease in testing with increased pool size.

Probit analysis was performed from combined runs to generate an LOD of 135.02 Table S1 ).

Sample pooling as an accessible method to increase testing capacity is dependent on a valid approach to mitigate altered target stability and sensitivity due to dilution in a variable matrix. Results from this study demonstrate the relative stability to pool 3, 5, and 10 nare swabs prior to RNA extraction for RT-qPCR analysis using the TaqPath Estimations are coincident with US-FDA recommendations for pooling method validation version July 28, 2020 [12] .

Emerging SARS-CoV-2 variants exhibit point mutations that are not only advantageous to strain proliferation via enhanced infectivity, transmissibility, and capacity to evade host immunity, but have also demonstrated to confound target identification of RT-qPCR diagnostics [13] . Variant of concern (VOC) B.1.1.7 (alpha variant) harbors a 6nucleotide deletion in the spike gene, a mutation commonly referred to as ΔH69/ΔV70, which has affected the TaqPath COVID-19 Combo Kit sensitivity towards the S gene, causing S-gene target failure (SGTF) [14] . Of the 40 samples that demonstrated SGTF, the ratio of asymptomatic to symptomatic cases of 3:1 was consistent with the case ratio of the LSTC positive sample repository, thus a correlation between symptomology and proxy variant detection cannot be stated. Independent of SGTF, the S gene demonstrated the lowest LOD, greatest variability in the negative sample matrix, and was the only target loss in pools of 5 and 10, therefore prevalence of VOCs may be J o u r n a l P r e -p r o o f irrelevant with consideration for the inherently improved positive predictive value of deconvolution methods that would incidentally refine proxy variant detection.

Nevertheless, to supplement testing reduction, asymptomatic samples can be pooled while samples from symptomatic collection sites can continue to be tested individually.

The COVID-19 pandemic has disproportionately affected the mission of IHE with an impact ranging from increased maintenance costs for university administrations to increased pressures on academic performance of students and faculty members. The LSTC has performed over 1 million tests that has helped mitigate SARS-CoV-2 transmission for nearly 2000 cases by informing individual quarantine measures and state contact tracing programs. High-complexity diagnostics, such as RT-qPCR, maintain numerous components that have significant impact on the reproducibility of the assay and all potential pooling formats would require specific validation. An efficient workflow design at the LSTC involves aliquoting fresh sample into five 1 mL 96-well plates that are then combined into a single master 1 mL 96-well plate for extraction. Sample tracking is facilitated by the laboratory information management system and impact to turn-around-times is expected to amount to no more than an additional <24 hours, allowing the LSTC to keep <48 hours reporting. Apparent volumes for routine population screening present a significant burden that a valid group testing strategy can help alleviate by providing an alternative both economically and environmentally beneficial. repeated well (invalid) rates of 2.5%, 5%, and 10% versus positive test prevalence. Insets highlight prevalence range from 1% to 10%. Bottom row: Increase (as percent difference over a hypothetical 0% repeat rate) in amount of testing by repeated well rates of 2.5%, 5%, and 10% versus positive test prevalence. 3-pool, black circles; 5-pool, light great squares; 10-pool, dark grey triangles. 

Fair Allocation of Scarce Medical Resources in the Time of Covid-19

Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States

The COVID-19 pandemic: Impacts on cities and major lessons for urban planning, design, and management

Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy

The implications of silent transmission for the control of COVID-19 outbreaks

ad: Clinical testing for COVID-19

Polyester nasal swabs collected dry tube are a robust and inexpensive, minimal self-collection kit for SARS-CoV-2 testing

Group testing identification: Objective functions, implementation, and multiplex assays [Doctoral dissertation

Cost Effectiveness of Sample Pooling to Test for SARS-CoV-2

Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools

Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings

Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency -Molecular Diagnostic Template for Laboratories

Facing the wrath of enigmatic mutations: A review on the emergence of SARS-CoV-2 variants amid COVID-19 pandemic

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70

The authors would like to thank Dr. Christopher Bilder for accommodating our inquiries, Ciara Cheli-Colando for providing metrics, and the tireless efforts of all at the LSTC.